The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nietfield, W.
Right arrow Articles by Meyerhans, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nietfield, W.
Right arrow Articles by Meyerhans, A.

The Journal of Immunology, Vol 154, Issue 5 2189-2197, Copyright © 1995 by American Association of Immunologists


ARTICLES

Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope

W Nietfield, M Bauer, M Fevrier, R Maier, B Holzwarth, R Frank, B Maier, Y Riviere and A Meyerhans
Department of Virology, University of Freiburg, Germany.

Previous studies on the variation of an immunodominant HLA-B27- restricted HIV-1 gag p24 epitope (KRWIIL GLNK, amino acids 263-272) have demonstrated the persistence of variants recognized by CTL. Sequence comparisons of HIV isolates showed that this region is relatively conserved and as a consequence might restrict antigenic variation. To evaluate the possibility of HIV-1 to yield infectious mutants of this epitope that lack the ability to bind to HLA-B27 or escape HLA-B27-restricted CTL recognition, single-point mutations were constructed in the infectious molecular clone of HIV-1 Lai. Changes of arginine 264, the anchor amino acid for HLA-B27, to lysine or glycine resulted in infectious HIV-1 variants. The respective synthetic peptides showed reduced ability to sensitize target cells for CTL recognition and a corresponding loss of binding affinity to HLA-B27. In contrast, mutation of glycine 269 to lysine or glutamate abrogated HIV- 1 infectivity. The corresponding peptides were able to bind to HLA-B27 but were not recognized by CTL. These data show that HIV-1 tolerates some genetic variation of the HLA-B27-restricted CTL epitope in gag p24 and that single-point mutations can alter quantitatively the immunologic properties. Further, it demonstrates that the mere nonrecognition of peptides derived from quasispecies analysis of small regions might simply correspond to nonviable virus variants and cannot be taken as evidence for CTL escape mutants. Together with the previously published data on the persistence of CTL epitopes, these results suggest that CTL do not play a major role in driving HIV-1 evolution in vivo.


This article has been cited by other articles:


Home page
J. Virol.Home page
A. Schneidewind, M. A. Brockman, J. Sidney, Y. E. Wang, H. Chen, T. J. Suscovich, B. Li, R. I. Adam, R. L. Allgaier, B. R. Mothe, et al.
Structural and Functional Constraints Limit Options for Cytotoxic T-Lymphocyte Escape in the Immunodominant HLA-B27-Restricted Epitope in Human Immunodeficiency Virus Type 1 Capsid
J. Virol., June 1, 2008; 82(11): 5594 - 5605.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Liu, J. McNevin, H. Zhao, D. M. Tebit, R. M. Troyer, M. McSweyn, A. K. Ghosh, D. Shriner, E. J. Arts, M. J. McElrath, et al.
Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape
J. Virol., November 15, 2007; 81(22): 12179 - 12188.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Schneidewind, M. A. Brockman, R. Yang, R. I. Adam, B. Li, S. Le Gall, C. R. Rinaldo, S. L. Craggs, R. L. Allgaier, K. A. Power, et al.
Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication
J. Virol., November 15, 2007; 81(22): 12382 - 12393.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. C. Karlsson, J. M. Chapman, B. D. Heiken, R. Hoh, E. G. Kallas, J. N. Martin, F. M. Hecht, S. G. Deeks, and D. F. Nixon
Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol
J. Virol., October 15, 2007; 81(20): 11543 - 11548.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Honeyborne, A. Prendergast, F. Pereyra, A. Leslie, H. Crawford, R. Payne, S. Reddy, K. Bishop, E. Moodley, K. Nair, et al.
Control of Human Immunodeficiency Virus Type 1 Is Associated with HLA-B*13 and Targeting of Multiple Gag-Specific CD8+ T-Cell Epitopes
J. Virol., April 1, 2007; 81(7): 3667 - 3672.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. S. Seaman, S. Santra, M. H. Newberg, V. Philippon, K. Manson, L. Xu, R. S. Gelman, D. Panicali, J. R. Mascola, G. J. Nabel, et al.
Vaccine-Elicited Memory Cytotoxic T Lymphocytes Contribute to Mamu-A*01-Associated Control of Simian/Human Immunodeficiency Virus 89.6P Replication in Rhesus Monkeys
J. Virol., April 15, 2005; 79(8): 4580 - 4588.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. W. Peyerl, H. S. Bazick, M. H. Newberg, D. H. Barouch, J. Sodroski, and N. L. Letvin
Fitness Costs Limit Viral Escape from Cytotoxic T Lymphocytes at a Structurally Constrained Epitope
J. Virol., December 15, 2004; 78(24): 13901 - 13910.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. H. O'Connor, A. B. McDermott, K. C. Krebs, E. J. Dodds, J. E. Miller, E. J. Gonzalez, T. J. Jacoby, L. Yant, H. Piontkivska, R. Pantophlet, et al.
A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation
J. Virol., December 15, 2004; 78(24): 14012 - 14022.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. H. O'Connor, B. R. Mothe, J. T. Weinfurter, S. Fuenger, W. M. Rehrauer, P. Jing, R. R. Rudersdorf, M. E. Liebl, K. Krebs, J. Vasquez, et al.
Major Histocompatibility Complex Class I Alleles Associated with Slow Simian Immunodeficiency Virus Disease Progression Bind Epitopes Recognized by Dominant Acute-Phase Cytotoxic-T-Lymphocyte Responses
J. Virol., August 15, 2003; 77(16): 9029 - 9040.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
O. O. Yang, P. T. N. Sarkis, A. Ali, J. D. Harlow, C. Brander, S. A. Kalams, and B. D. Walker
Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes
J. Exp. Med., May 19, 2003; 197(10): 1365 - 1375.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Altfeld, M. M. Addo, R. L. Eldridge, X. G. Yu, S. Thomas, A. Khatri, D. Strick, M. N. Phillips, G. B. Cohen, S. A. Islam, et al.
Vpr Is Preferentially Targeted by CTL During HIV-1 Infection
J. Immunol., September 1, 2001; 167(5): 2743 - 2752.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
I. M. Rouzine, A. Rodrigo, and J. M. Coffin
Transition between Stochastic Evolution and Deterministic Evolution in the Presence of Selection: General Theory and Application to Virology
Microbiol. Mol. Biol. Rev., March 1, 2001; 65(1): 151 - 185.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Addo, M. Altfeld, E. S. Rosenberg, R. L. Eldridge, M. N. Philips, K. Habeeb, A. Khatri, C. Brander, G. K. Robbins, G. P. Mazzara, et al.
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
PNAS, February 13, 2001; 98(4): 1781 - 1786.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. D. Kelleher, C. Long, E. C. Holmes, R. L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, et al.
Clustered Mutations in HIV-1 gag Are Consistently Required for Escape from HLA-B27-restricted Cytotoxic T Lymphocyte Responses
J. Exp. Med., February 5, 2001; 193(3): 375 - 386.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. K. Sewell, D. A. Price, A. Oxenius, A. D. Kelleher, and R. E. Phillips
Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape
Stem Cells, July 1, 2000; 18(4): 230 - 244.
[Abstract] [Full Text]


Home page
CVIHome page
J. Iroegbu, M. Birk, U. Lazdina, A. Sonnerborg, and M. Sallberg
Variability and Immunogenicity of Human Immunodeficiency Virus Type 1 p24 Gene Quasispecies
Clin. Vaccine Immunol., May 1, 2000; 7(3): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Ishikawa, D. Kono, J. Chung, P. Fowler, A. Theofilopoulos, S. Kakumu, and F. V. Chisari
Polyclonality and Multispecificity of the CTL Response to a Single Viral Epitope
J. Immunol., December 1, 1998; 161(11): 5842 - 5850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.